Centerpoint Advisors’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$231K Hold
1,080
0.08% 79
2025
Q4
$185K Sell
1,080
-7
-0.6% -$1.09K 0.06% 87
2025
Q3
$146K Buy
1,087
+80
+8% +$8.47K 0.05% 106
2025
Q2
$98K Buy
1,007
+7
+0.7% +$555 0.03% 118
2025
Q1
$73K Hold
1,000
0.03% 138
2024
Q4
$72K Hold
1,000
0.03% 148
2024
Q3
$82K Hold
1,000
0.03% 137
2024
Q2
$106K Hold
1,000
0.04% 127
2024
Q1
$97K Hold
1,000
0.04% 128
2023
Q4
$78K Sell
1,000
-170
-15% -$11.6K 0.03% 130
2023
Q3
$73K Hold
1,170
0.03% 135
2023
Q2
$75K Hold
1,170
0.03% 138
2023
Q1
$62K Buy
1,170
+30
+3% +$1.47K 0.03% 142
2022
Q4
$48K Hold
1,140
0.02% 143
2022
Q3
$42K Buy
1,140
+1,000
+714% +$44.5K 0.02% 140
2022
Q2
$6K Hold
140
﹤0.01% 258
2022
Q1
$7K Hold
140
﹤0.01% 250
2021
Q4
$10K Buy
+140
New +$8.78K ﹤0.01% 222

Other funds holding LRCX

Centerpoint Advisors's LRCX Position: Q1 2026 in Review

Centerpoint Advisors held its Lam Research (LRCX) position steady in Q1 2026 at 1,080 shares worth $231K. The position accounts for 0.08% of the portfolio, ranked #79.

Centerpoint Advisors first reported a position in LRCX in Q4 2021 and has held it in 18 quarters since. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

  • Centerpoint Advisors held 1,080 shares of Lam Research worth $231K as of Q1 2026.
  • Centerpoint Advisors left its Lam Research share count unchanged in Q1 2026.
  • Lam Research made up 0.08% of Centerpoint Advisors's portfolio in Q1 2026, its #79 holding.
  • Centerpoint Advisors first reported a position in Lam Research in Q4 2021 and has held it in 18 quarters since.
  • 2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on Centerpoint Advisors's 13F filing for Q1 2026, filed 7 May 2026.